Health Care · Biological Products, (No Diagnostic Substances) · Nasdaq · CIK 1817241 · FYE Dec 31 · Prices AT CLOSE 2026-08-19 (USD) Last $11.70 · Day +0.17% · Mkt cap $571M · 1Y +319.4% · Off 52W high −19.5% · Vol (1Y) 184.5% Price2024-07-19 → 2026-08-19 ARTV close: $12.0 on 2024-07-19 to $11.7 on 2026-08-19. Split-adj closes · 240 of 520 · price returnⓘ At a glance | Short interest3.9% of sh out | | Days to cover5.1d | | 13F net flow (QoQ)−0.68% | | Top-10 13F concentration94.6% | | Next report (est.)2026-11-04 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | Sales (TTM)$0 | | Earnings (TTM)-$90.8M | | ROE−56.5% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD+172.7% | | 1Y+319.4% | | Since incept. (ann.)−1.2% |
Total return · from 2024-07-19ⓘ Risk | Ann. volatility (1Y)184.5% | | Ann. volatility (3Y)153.1% | | Sharpe (1Y)1.41 | | Sharpe (3Y)0.62 | | Max drawdown (1Y)−49.2% | | Max drawdown (3Y)−90.7% | | Beta (3Y vs SPY)2.23 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| RA CAPITAL MANAGEMENT, L.P. | 9.9M | $63M | 39.87% | +0.0% | | 5AM Venture Management, LLC | 2.4M | $15M | 9.52% | +0.0% | | Venrock Adviser, LLC | 1.6M | $10M | 6.51% | +0.0% | | venBio Partners LLC | 531,337 | $3M | 2.15% | −18.1% | | FRANKLIN RESOURCES INC | 520,327 | $3M | 2.11% | +0.0% | | Revelation Capital Management, LLC | 299,311 | $2M | 1.21% | +0.0% | | BlackRock, Inc. | 213,388 | $1M | 0.86% | +0.4% | | VANGUARD CAPITAL MANAGEMENT LLC | 207,686 | $1M | 0.84% | new |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-06 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-06 | −$0.63 | — | — | — | | 2026-03-31 | 2026-05-08 | −$0.95 | — | — | — | | 2025-09-30 | 2025-11-12 | −$0.88 | — | — | — | | 2025-06-30 | 2025-08-06 | −$0.87 | — | — | — |
As-reported XBRL · next 2026-11-04 est.ⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
|
